Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Diabetic neuropathy.

Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL, Bril V, Russell JW, Viswanathan V.

Nat Rev Dis Primers. 2019 Jun 13;5(1):41. doi: 10.1038/s41572-019-0092-1. Review.

PMID:
31197153
2.

Can diabetic polyneuropathy and foot ulcers in patients with type 2 diabetes be accurately identified based on ICD-10 hospital diagnoses and drug prescriptions?

Christensen DH, Knudsen ST, Nicolaisen SK, Andersen H, Callaghan BC, Finnerup NB, Jensen TS, Thomsen RW.

Clin Epidemiol. 2019 May 1;11:311-321. doi: 10.2147/CLEP.S197474. eCollection 2019.

3.

Out-of-pocket costs are on the rise for commonly prescribed neurologic medications.

Callaghan BC, Reynolds E, Banerjee M, Kerber KA, Skolarus LE, Magliocco B, Esper GJ, Burke JF.

Neurology. 2019 May 28;92(22):e2604-e2613. doi: 10.1212/WNL.0000000000007564. Epub 2019 May 1.

PMID:
31043472
4.

Impact of early headache neuroimaging on time to malignant brain tumor diagnosis: A retrospective cohort study.

Carey MR, Callaghan BC, Kerber KA, Skolarus LE, Burke JF.

PLoS One. 2019 Feb 1;14(2):e0211599. doi: 10.1371/journal.pone.0211599. eCollection 2019.

5.

Claims data analyses unable to properly characterize the value of neurologists in epilepsy care.

Hill CE, Lin CC, Burke JF, Kerber KA, Skolarus LE, Esper GJ, Magliocco B, Callaghan BC.

Neurology. 2019 Feb 26;92(9):e973-e987. doi: 10.1212/WNL.0000000000007004. Epub 2019 Jan 23.

PMID:
30674587
6.

Longitudinal pattern of pain medication utilization in peripheral neuropathy patients.

Callaghan BC, Reynolds E, Banerjee M, Kerber KA, Skolarus LE, Burke JF.

Pain. 2019 Mar;160(3):592-599. doi: 10.1097/j.pain.0000000000001439.

PMID:
30418352
7.

Assessment of Proposed Changes to Evaluation and Management Billing Levels by Physician Specialty.

Callaghan BC, Burke JF, Skolarus LE, Kerber KA.

JAMA Neurol. 2018 Oct 31. doi: 10.1001/jamaneurol.2018.3794. [Epub ahead of print] No abstract available.

PMID:
30383157
8.

Unintended consequences of Mayo paraneoplastic evaluations.

Ebright MJ, Li SH, Reynolds E, Burke JF, Claytor BR, Grisold A, Banerjee M, Callaghan BC.

Neurology. 2018 Nov 27;91(22):e2057-e2066. doi: 10.1212/WNL.0000000000006577. Epub 2018 Oct 26.

PMID:
30366974
9.

Reply to "Diagnosing Neuropathy in an Obese Patient": Measuring neuropathy in obese populations: Nerve conduction studies.

Callaghan BC, Feldman EL.

Clin Neurophysiol. 2018 Sep;129(9):2050. doi: 10.1016/j.clinph.2018.06.004. Epub 2018 Jun 14. No abstract available.

PMID:
29921550
10.

Measuring neuropathy in obese populations: Challenge accepted. Reply to "Diagnostic accuracy of neuropathy tests in obese population remains elusive".

Callaghan BC, Feldman EL.

Clin Neurophysiol. 2018 Jul;129(7):1504-1505. doi: 10.1016/j.clinph.2018.03.040. Epub 2018 Apr 16. No abstract available.

PMID:
29729887
11.

What's happening in Innovations in Care Delivery.

Callaghan BC, Kerber KA.

Neurology. 2018 May 1;90(18):841. doi: 10.1212/WNL.0000000000005433. No abstract available.

PMID:
29712805
12.

Diabetes and obesity are the main metabolic drivers of peripheral neuropathy.

Callaghan BC, Gao L, Li Y, Zhou X, Reynolds E, Banerjee M, Pop-Busui R, Feldman EL, Ji L.

Ann Clin Transl Neurol. 2018 Feb 14;5(4):397-405. doi: 10.1002/acn3.531. eCollection 2018 Apr.

13.

What's happening in Innovations in Care Delivery.

Callaghan BC, Kerber KA.

Neurology. 2018 Apr 3;90(14):651. doi: 10.1212/WNL.0000000000005273. No abstract available.

PMID:
29610227
14.

What's Happening In Innovations in Care Delivery.

Callaghan BC, Kerber KA.

Neurology. 2018 Mar 6;90(10):463. doi: 10.1212/WNL.0000000000005136. No abstract available.

PMID:
29507132
15.

Association of neurologist care with headache expenditures: A population-based, longitudinal analysis.

Ney JP, Sico JJ, Klein BC, Magliocco B, Callaghan BC, Esper GJ.

Cephalalgia. 2018 Oct;38(12):1876-1884. doi: 10.1177/0333102418762572. Epub 2018 Mar 4.

PMID:
29504480
16.

Risk Factors for Incident Diabetic Polyneuropathy in a Cohort With Screen-Detected Type 2 Diabetes Followed for 13 Years: ADDITION-Denmark.

Andersen ST, Witte DR, Dalsgaard EM, Andersen H, Nawroth P, Fleming T, Jensen TM, Finnerup NB, Jensen TS, Lauritzen T, Feldman EL, Callaghan BC, Charles M.

Diabetes Care. 2018 May;41(5):1068-1075. doi: 10.2337/dc17-2062. Epub 2018 Feb 27.

PMID:
29487078
17.

What's happening in Innovations in Care Delivery.

Callaghan BC, Kerber KA.

Neurology. 2018 Feb 6;90(6):274. doi: 10.1212/WNL.0000000000004941. No abstract available.

PMID:
29438020
18.

Better diagnostic accuracy of neuropathy in obesity: A new challenge for neurologists.

Callaghan BC, Xia R, Reynolds E, Banerjee M, Burant C, Rothberg A, Pop-Busui R, Villegas-Umana E, Feldman EL.

Clin Neurophysiol. 2018 Mar;129(3):654-662. doi: 10.1016/j.clinph.2018.01.003. Epub 2018 Jan 16.

19.

The association of neurologists with headache health care utilization and costs.

Callaghan BC, Burke JF, Kerber KA, Skolarus LE, Ney JP, Magliocco B, Esper GJ.

Neurology. 2018 Feb 6;90(6):e525-e533. doi: 10.1212/WNL.0000000000004925. Epub 2018 Jan 10.

20.

Obesity and the nervous system: more questions - Authors' reply.

Callaghan BC, O'Brien PD, Hinder LM, Feldman EL.

Lancet Neurol. 2017 Oct;16(10):774. doi: 10.1016/S1474-4422(17)30293-4. Epub 2017 Sep 12. No abstract available.

PMID:
28920882
21.

Dizziness Symptom Type Prevalence and Overlap: A US Nationally Representative Survey.

Kerber KA, Callaghan BC, Telian SA, Meurer WJ, Skolarus LE, Carender W, Burke JF.

Am J Med. 2017 Dec;130(12):1465.e1-1465.e9. doi: 10.1016/j.amjmed.2017.05.048. Epub 2017 Jul 21.

PMID:
28739195
22.

Electrodiagnostic tests are unlikely to change management in those with a known cause of typical distal symmetric polyneuropathy.

Callaghan BC, Burke JF, Kerber KA, Albers JW, Feldman EL.

Muscle Nerve. 2017 Sep;56(3):E25. doi: 10.1002/mus.25713. Epub 2017 Jun 22. No abstract available.

23.

Neurological consequences of obesity.

O'Brien PD, Hinder LM, Callaghan BC, Feldman EL.

Lancet Neurol. 2017 Jun;16(6):465-477. doi: 10.1016/S1474-4422(17)30084-4. Review.

24.

Author response: Neuroimaging overuse is more common in Medicare compared with the VA.

Burke JF, Callaghan BC.

Neurology. 2017 Feb 7;88(6):608. doi: 10.1212/WNL.0000000000003594. No abstract available.

PMID:
28167625
25.

Author response: Neuroimaging overuse is more common in Medicare compared with the VA.

Burke JF, Callaghan BC.

Neurology. 2017 Feb 7;88(6):607-608. doi: 10.1212/WNL.0000000000003581. No abstract available.

PMID:
28167623
26.

Mediators of diabetic neuropathy: is hyperglycemia the only culprit?

Grisold A, Callaghan BC, Feldman EL.

Curr Opin Endocrinol Diabetes Obes. 2017 Apr;24(2):103-111. doi: 10.1097/MED.0000000000000320. Review.

27.

Association Between Metabolic Syndrome Components and Polyneuropathy in an Obese Population.

Callaghan BC, Xia R, Reynolds E, Banerjee M, Rothberg AE, Burant CF, Villegas-Umana E, Pop-Busui R, Feldman EL.

JAMA Neurol. 2016 Dec 1;73(12):1468-1476. doi: 10.1001/jamaneurol.2016.3745.

28.

Neuroimaging overuse is more common in Medicare compared with the VA.

Burke JF, Kerr EA, McCammon RJ, Holleman R, Langa KM, Callaghan BC.

Neurology. 2016 Aug 23;87(8):792-8. doi: 10.1212/WNL.0000000000002963. Epub 2016 Jul 8.

29.

Increased ratio of circulating neutrophils to monocytes in amyotrophic lateral sclerosis.

Murdock BJ, Bender DE, Kashlan SR, Figueroa-Romero C, Backus C, Callaghan BC, Goutman SA, Feldman EL.

Neurol Neuroimmunol Neuroinflamm. 2016 Jun 1;3(4):e242. doi: 10.1212/NXI.0000000000000242. eCollection 2016 Aug.

30.

Screening for novel hexanucleotide repeat expansions at ALS- and FTD-associated loci.

He F, Jones JM, Figueroa-Romero C, Zhang D, Feldman EL, Goutman SA, Meisler MH, Callaghan BC, Todd PK.

Neurol Genet. 2016 May 11;2(3):e71. doi: 10.1212/NXG.0000000000000071. eCollection 2016 Jun.

31.

Leprosy as a Cause of Distal Symmetric Polyneuropathy--Reply.

Callaghan BC, Price RS, Feldman EL.

JAMA. 2016 May 17;315(19):2123-4. doi: 10.1001/jama.2016.1118. No abstract available.

PMID:
27187311
32.

Association of Environmental Toxins With Amyotrophic Lateral Sclerosis.

Su FC, Goutman SA, Chernyak S, Mukherjee B, Callaghan BC, Batterman S, Feldman EL.

JAMA Neurol. 2016 Jul 1;73(7):803-11. doi: 10.1001/jamaneurol.2016.0594. Erratum in: JAMA Neurol. 2017 May 1;74(5):612.

33.

Pearls & Oy-sters: The importance of atypical features and tracking progression in patients misdiagnosed with ALS.

Jacobson RD, Goutman SA, Callaghan BC.

Neurology. 2016 Mar 29;86(13):e136-9. doi: 10.1212/WNL.0000000000002522. No abstract available.

34.

Medicare's Reimbursement Reduction for Nerve Conduction Studies: Effect on Use and Payments.

Callaghan BC, Burke JF, Skolarus LE, Jacobson RD, De Lott LB, Kerber KA.

JAMA Intern Med. 2016 May 1;176(5):697-9. doi: 10.1001/jamainternmed.2016.0162. No abstract available.

35.

Medicare Part D payments for neurologist-prescribed drugs.

De Lott LB, Burke JF, Kerber KA, Skolarus LE, Callaghan BC.

Neurology. 2016 Apr 19;86(16):1491-8. doi: 10.1212/WNL.0000000000002589. Epub 2016 Mar 23.

36.

The changing US health-care landscape: opportunities and challenges.

Callaghan BC, Burke JF, Kerber KA, Skolarus LE.

Lancet Neurol. 2016 Apr;15(4):351-2. doi: 10.1016/S1474-4422(16)00064-8. No abstract available.

PMID:
26971653
37.

Metabolic Syndrome Components Are Associated With Symptomatic Polyneuropathy Independent of Glycemic Status.

Callaghan BC, Xia R, Banerjee M, de Rekeneire N, Harris TB, Newman AB, Satterfield S, Schwartz AV, Vinik AI, Feldman EL, Strotmeyer ES; Health ABC Study.

Diabetes Care. 2016 May;39(5):801-7. doi: 10.2337/dc16-0081. Epub 2016 Mar 10.

38.

Electrodiagnostic Tests in Polyneuropathy and Radiculopathy.

Callaghan BC, Burke JF, Feldman EL.

JAMA. 2016 Jan 19;315(3):297-8. doi: 10.1001/jama.2015.16832. No abstract available.

39.

Distal Symmetric Polyneuropathy: A Review.

Callaghan BC, Price RS, Feldman EL.

JAMA. 2015 Nov 24;314(20):2172-81. doi: 10.1001/jama.2015.13611. Review.

40.

Neurology Choosing Wisely recommendations: 74 and growing.

Callaghan BC, De Lott LB, Kerber KA, Burke JF, Skolarus LE.

Neurol Clin Pract. 2015 Oct;5(5):439-447.

41.

The Importance of Rare Subtypes in Diagnosis and Treatment of Peripheral Neuropathy: A Review.

Callaghan BC, Price RS, Chen KS, Feldman EL.

JAMA Neurol. 2015 Dec;72(12):1510-8. doi: 10.1001/jamaneurol.2015.2347. Review.

42.

Medicare payments to the neurology workforce in 2012.

Skolarus LE, Burke JF, Callaghan BC, Becker A, Kerber KA.

Neurology. 2015 Apr 28;84(17):1796-802. doi: 10.1212/WNL.0000000000001515. Epub 2015 Apr 1.

43.

Headache neuroimaging: Routine testing when guidelines recommend against them.

Callaghan BC, Kerber KA, Pace RJ, Skolarus L, Cooper W, Burke JF.

Cephalalgia. 2015 Nov;35(13):1144-52. doi: 10.1177/0333102415572918. Epub 2015 Feb 12.

44.

Headaches and neuroimaging—reply.

Callaghan BC, Kerber KA, Burke JF.

JAMA Intern Med. 2015 Feb;175(2):313-4. doi: 10.1001/jamainternmed.2014.7014. No abstract available.

PMID:
25642671
45.

The evaluation of distal symmetric polyneuropathy: utilisation and expenditures by community neurologists.

Callaghan BC, Kerber KA, Banerjee M, Feldman EL, Morgenstern LB, Longoria R, Rodgers A, Longwell P, Lisabeth LD.

J Neurol Neurosurg Psychiatry. 2016 Jan;87(1):113-4. doi: 10.1136/jnnp-2014-307575. Epub 2015 Jan 20. No abstract available.

PMID:
25604430
46.

Painful diabetic neuropathy: many similarly effective therapies with widely dissimilar costs.

Callaghan BC, Feldman EL.

Ann Intern Med. 2014 Nov 4;161(9):674-5. doi: 10.7326/M14-2157. No abstract available.

PMID:
25364890
47.

Multimodal MRI as a diagnostic biomarker for amyotrophic lateral sclerosis.

Foerster BR, Carlos RC, Dwamena BA, Callaghan BC, Petrou M, Edden RA, Mohamed MA, Welsh RC, Barker PB, Feldman EL, Pomper MG.

Ann Clin Transl Neurol. 2014 Feb;1(2):107-14. doi: 10.1002/acn3.30. Epub 2014 Jan 13.

48.

Role of neurologists and diagnostic tests on the management of distal symmetric polyneuropathy.

Callaghan BC, Kerber KA, Lisabeth LL, Morgenstern LB, Longoria R, Rodgers A, Longwell P, Feldman EL.

JAMA Neurol. 2014 Sep;71(9):1143-9. doi: 10.1001/jamaneurol.2014.1279.

49.

Impact of state Medicaid coverage on utilization of inpatient rehabilitation facilities among patients with stroke.

Skolarus LE, Burke JF, Morgenstern LB, Meurer WJ, Adelman EE, Kerber KA, Callaghan BC, Lisabeth LD.

Stroke. 2014 Aug;45(8):2472-4. doi: 10.1161/STROKEAHA.114.005882. Epub 2014 Jul 8.

50.

Environmental risk factors and amyotrophic lateral sclerosis (ALS): a case-control study of ALS in Michigan.

Yu Y, Su FC, Callaghan BC, Goutman SA, Batterman SA, Feldman EL.

PLoS One. 2014 Jun 30;9(6):e101186. doi: 10.1371/journal.pone.0101186. eCollection 2014.

Supplemental Content

Loading ...
Support Center